Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers

by Lucas, Steven M., Heath, Elisabeth I.
Published 2012

Apocrine carcinoma of the face in a 62-year-old Asian man

by Kumar, Sarwan, Zafar, Syed F., Raufi, Ali M., Heath, Elisabeth I.
Published 2011

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

by Conley-LaComb, M. Katie, Semaan, Louie, Singareddy, Rajareddy, Li, Yanfeng, Heath, Elisabeth I., Kim, Seongho, Cher, Michael L., Chinni, Sreenivasa R.
Published 2016

Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

by Bhatia, Shailender, Curti, Brendan, Ernstoff, Marc S, Gordon, Michael, Heath, Elisabeth I, Miller, Wilson H, Puzanov, Igor, Quinn, David I, Flaig, Thomas W, VanVeldhuizen, Peter, Byrnes-Blake, Kelly, Freeman, Jeremy A, Bittner, Rachel, Hunder, Naomi, Souza, Sonia, Thompson, John A
Published 2014

Activity of enzalutamide in men with metastatic castration resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel

by Cheng, Heather H., Gulati, Roman, Azad, Arun, Nadal, Rosa, Twardowski, Przemyslaw, Vaishampayan, Ulka N., Agarwal, Neeraj, Heath, Elisabeth I., Pal, Sumanta K., Rehman, Hibba-tul, Leiter, Amanda, Batten, Julia A., Montgomery, R. Bruce, Galsky, Matthew D., Antonarakis, Emmanuel S., Chi, Kim N., Yu, Evan Y.
Published 2015